We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will China ETFs Gain on Better-Than-Expected Trade Data?
Read MoreHide Full Article
The world’s second-largest economy has cheered investors with encouraging trade data. China’s export and import numbers did witness a year-over-year decline in March but successfully beat analyst estimates. According to data from the General Administration of Customs, China’s exports declined 6.6% year over year in March, while imports slid 0.9% in the same month. The figures displayed smaller-than-expected contraction, as against expectations of a year-over-year decline of 14% in exports in March and a 9.5% fall in imports (per a Reuters’ poll). China’s March trade surplus came in at $19.9 billion, in comparison to analysts’ expectations of $18.55 billion.
Li Kuiwen, spokesperson for the General Administration of Customs, has said that the U.S.-China phase one trade deal is gradually being implied. Moreover, backed by the encouraging trade data, China’s Shanghai Composite index rose 1.59% on Apr 14, along with a 1.93% rise in the blue-chip CSI300 index on the same day.
Another data set released recently shows that China is gradually recovering from the coronavirus outbreak. China’s official Purchasing Manager Index (PMI) for March managed to surpass expectations despite its economy being hit by the pandemic. The PMI for March came in at 52, beating analysts’ expectations of 45 (per a Reuters’ poll). The metric compares favorably with the record low level of 35.7 seen in February. Notably, PMI readings above 50 indicate expansion. China’s official non-manufacturing PMI came in at 52.3 in March comparing favorably with 29.6 in February (read: Is it the Right Time to Buy China ETFs? Let's Explore).
China is, nevertheless, still exposed to risks of the second wave of new coronavirus infections and drop in global economic growth. The slowing global economic growth might result in declining export numbers in China. Also, analysts estimate a contraction in its economy in the first quarter of 2020. Deutsche Bank sees the global economy falling into a coronavirus-led recession in the first half of 2020.
Meanwhile, China’s central bank has been taking adequate measures. It injected 100 billion yuan ($14 billion) via the one-year medium-term lending facility, trimming the rate to 2.95% from 3.15%. The banks’ reserve ratio has also been reduced by 50 basis points (bps). The move is expected to inject about 200 billion yuan of liquidity into the financial system.
ETFs in Focus
Against this backdrop, investors can keep a tab on a few China ETFs like iShares MSCI China ETF (MCHI - Free Report) , iShares China Large-Cap ETF (FXI - Free Report) , Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR - Free Report) , SPDR S&P China ETF (GXC - Free Report) , iShares MSCI China A ETF (CNYA - Free Report) and Invesco Golden Dragon China ETF (PGJ - Free Report) .
This fund seeks long-term growth by tracking the investment returns, before fees and expenses, of the FTSE China 50 Index. It comprises 50 holdings. The fund’s AUM is $4.16 billion and the expense ratio, 0.74% (read: Will China ETFs Gain on New Round of Monetary Easing?).
ASHR
This fund tracks the CSI 300 Index. It comprises 302 holdings. The fund’s AUM is $1.66 billion and the expense ratio is 0.65%.
GXC
The fund seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P China BMI Index. It comprises 733 holdings. The fund’s AUM is $1.24 billion and the expense ratio, 0.59%.
This fund follows the NASDAQ Golden Dragon China Index, which offers exposure to the U.S. exchange-listed companies headquartered or incorporated in the People’s Republic of China. It holds a basket of 65 stocks. The product has an AUM of $157.2 million and charges 70 bps in annual fees.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Will China ETFs Gain on Better-Than-Expected Trade Data?
The world’s second-largest economy has cheered investors with encouraging trade data. China’s export and import numbers did witness a year-over-year decline in March but successfully beat analyst estimates. According to data from the General Administration of Customs, China’s exports declined 6.6% year over year in March, while imports slid 0.9% in the same month. The figures displayed smaller-than-expected contraction, as against expectations of a year-over-year decline of 14% in exports in March and a 9.5% fall in imports (per a Reuters’ poll). China’s March trade surplus came in at $19.9 billion, in comparison to analysts’ expectations of $18.55 billion.
Li Kuiwen, spokesperson for the General Administration of Customs, has said that the U.S.-China phase one trade deal is gradually being implied. Moreover, backed by the encouraging trade data, China’s Shanghai Composite index rose 1.59% on Apr 14, along with a 1.93% rise in the blue-chip CSI300 index on the same day.
Another data set released recently shows that China is gradually recovering from the coronavirus outbreak. China’s official Purchasing Manager Index (PMI) for March managed to surpass expectations despite its economy being hit by the pandemic. The PMI for March came in at 52, beating analysts’ expectations of 45 (per a Reuters’ poll). The metric compares favorably with the record low level of 35.7 seen in February. Notably, PMI readings above 50 indicate expansion. China’s official non-manufacturing PMI came in at 52.3 in March comparing favorably with 29.6 in February (read: Is it the Right Time to Buy China ETFs? Let's Explore).
China is, nevertheless, still exposed to risks of the second wave of new coronavirus infections and drop in global economic growth. The slowing global economic growth might result in declining export numbers in China. Also, analysts estimate a contraction in its economy in the first quarter of 2020. Deutsche Bank sees the global economy falling into a coronavirus-led recession in the first half of 2020.
Meanwhile, China’s central bank has been taking adequate measures. It injected 100 billion yuan ($14 billion) via the one-year medium-term lending facility, trimming the rate to 2.95% from 3.15%. The banks’ reserve ratio has also been reduced by 50 basis points (bps). The move is expected to inject about 200 billion yuan of liquidity into the financial system.
ETFs in Focus
Against this backdrop, investors can keep a tab on a few China ETFs like iShares MSCI China ETF (MCHI - Free Report) , iShares China Large-Cap ETF (FXI - Free Report) , Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR - Free Report) , SPDR S&P China ETF (GXC - Free Report) , iShares MSCI China A ETF (CNYA - Free Report) and Invesco Golden Dragon China ETF (PGJ - Free Report) .
MCHI
This fund tracks the MSCI China Index. It comprises 603 holdings. The fund’s AUM is $5.30 billion and the expense ratio is 0.59% (read: Should You Buy China ETFs as Coronavirus Cases Wane?).
FXI
This fund seeks long-term growth by tracking the investment returns, before fees and expenses, of the FTSE China 50 Index. It comprises 50 holdings. The fund’s AUM is $4.16 billion and the expense ratio, 0.74% (read: Will China ETFs Gain on New Round of Monetary Easing?).
ASHR
This fund tracks the CSI 300 Index. It comprises 302 holdings. The fund’s AUM is $1.66 billion and the expense ratio is 0.65%.
GXC
The fund seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P China BMI Index. It comprises 733 holdings. The fund’s AUM is $1.24 billion and the expense ratio, 0.59%.
CNYA
The fund tracks the MSCI China A Inclusion Index. It comprises 467 holdings. The fund’s AUM is $325.7 million and the expense ratio is 0.60% (read: What Coronavirus? These China ETFs Gained Past Month).
PGJ
This fund follows the NASDAQ Golden Dragon China Index, which offers exposure to the U.S. exchange-listed companies headquartered or incorporated in the People’s Republic of China. It holds a basket of 65 stocks. The product has an AUM of $157.2 million and charges 70 bps in annual fees.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>